Naya IP - Search Results

1

Post hoc analysis and claims of superiority in the EXCEL trial.

Naya IP, Andersson TL. Naya IP, et al. Respir Med. 2007 Mar;101(3):681-2; author reply 683. doi: 10.1016/j.rmed.2006.10.025. Epub 2006 Dec 12. Respir Med. 2007. PMID: 17166708 Free article. No abstract available.

2

The effect of budesonide/formoterol maintenance and reliever therapy on the risk of severe asthma exacerbations following episodes of high reliever use: an exploratory analysis of two randomised, controlled studies with comparisons to standard therapy.

Buhl R, Kuna P, Peters MJ, Andersson TL, Naya IP, Peterson S, Rabe KF. Buhl R, et al. Among authors: naya ip. Respir Res. 2012 Jul 20;13(1):59. doi: 10.1186/1465-9921-13-59. Respir Res. 2012. PMID: 22816878 Free PMC article. Clinical Trial.

3

Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma.

Buhl R, Creemers JP, Vondra V, Martelli NA, Naya IP, Ekström T. Buhl R, et al. Among authors: naya ip. Respir Med. 2003 Apr;97(4):323-30. doi: 10.1053/rmed.2002.1427. Respir Med. 2003. PMID: 12693793 Free article. Clinical Trial.

4

Budesonide/formoterol maintenance and reliever therapy versus conventional best practice.

Demoly P, Louis R, Søes-Petersen U, Naya I, Carlsheimer A, Worth H, Almeida J, Sears MR. Demoly P, et al. Respir Med. 2009 Nov;103(11):1623-32. doi: 10.1016/j.rmed.2009.07.018. Epub 2009 Sep 16. Respir Med. 2009. PMID: 19762222 Free article.

5

Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?

Vogelmeier C, D'Urzo A, Pauwels R, Merino JM, Jaspal M, Boutet S, Naya I, Price D. Vogelmeier C, et al. Eur Respir J. 2005 Nov;26(5):819-28. doi: 10.1183/09031936.05.00028305. Eur Respir J. 2005. PMID: 16264042 Free article. Clinical Trial.

6

Applying key learnings from the EMAX trial to clinical practice and future trial design in COPD.

Maltais F, Vogelmeier CF, Kerwin EM, Bjermer LH, Jones PW, Boucot IH, Lipson DA, Tombs L, Compton C, Naya IP. Maltais F, et al. Among authors: naya ip. Respir Med. 2022 Aug-Sep;200:106918. doi: 10.1016/j.rmed.2022.106918. Epub 2022 Jun 10. Respir Med. 2022. PMID: 35803172 Free article. Review.

7

Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma.

Bateman ED, Bantje TA, João Gomes M, Toumbis MG, Huber RM, Naya I, Eliraz A. Bateman ED, et al. Am J Respir Med. 2003;2(3):275-81. doi: 10.1007/BF03256655. Am J Respir Med. 2003. PMID: 14720008 Clinical Trial.

8

Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis.

Naya I, Tombs L, Lipson DA, Boucot I, Compton C. Naya I, et al. Respir Res. 2019 Mar 26;20(1):60. doi: 10.1186/s12931-019-1027-9. Respir Res. 2019. PMID: 30914064 Free PMC article.

9

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial.

Maltais F, Naya IP, Vogelmeier CF, Boucot IH, Jones PW, Bjermer L, Tombs L, Compton C, Lipson DA, Kerwin EM. Maltais F, et al. Among authors: naya ip. Respir Res. 2020 Oct 22;21(1):280. doi: 10.1186/s12931-020-01451-8. Respir Res. 2020. PMID: 33092591 Free PMC article. Clinical Trial.

10

Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids.

Virchow JC Jr, Prasse A, Naya I, Summerton L, Harris A. Virchow JC Jr, et al. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):578-85. doi: 10.1164/ajrccm.162.2.9905041. Am J Respir Crit Care Med. 2000. PMID: 10934090 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters